GLP1R and type 2 diabetes mellitus: Endogenous GLP-1 is degraded within minutes in vivo by the enzyme dipeptidyl peptidase-4 (DP-4), whereas liraglutide is a long-term GLP-1 receptor agonist that has been licensed for the treatment of T2DM [49].